ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Poonam Joshi1 , Aanchal Loshali2, Yogita Ale1, Gulafshan Parveen3, Purabi Saha1 and Vikas Jakhmola1
1Department of Pharmacy, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India.
2Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi,  India.
3Guru Nanak College of Pharmaceutical Sciences, Dehradun, Uttarakhand, India.
Article Number: 8263 | © The Author(s). 2022
J Pure Appl Microbiol. 2022;16(suppl 1):3048-3061.
Received: 21 November 2022 | Accepted: 07 December 2022 | Published online: 30 December 2022
Issue online: 30 December 2022

The outbreak of Monkeypox was declared a public health emergency of worldwide concern by WHO following the (COVID-19) pandemic. The number of reported cases of both suspicion and confirmation has increased in recent years, from over 19,000 between 2000 and 2019 to over 15,600 between 2021 and 2022, and day by day the cases of monkeypox have been reported in 12 member states to three WHO regions. As of May 21, 2022, 92 confirmed cases of monkeypox and 28 suspected cases had been reported to the WHO from more than 12 countries. By the 21st of June 2022, a total of 2677 confirmed cases had been recorded from the UK and other European and non-European countries. According to an extensive literature survey, the total number of registered cases of MPXV was 59,147 between January 2022 to September 14th, 2022, demonstrating that MPXV can spread significantly amongst people and may as a result pose a serious threat to public health with international repercussions. In clade II MPXV virus is currently occurring outside of Africa the WHO reported 25,047 confirmed cases as of August 2nd, 2022. Here, we review current better understanding, and studies on monkeypox, including its history, current scenario, epidemiology, causative agent, symptoms, diagnosis, treatment, limitations, and the new face of monkeypox, its unusual outbreak attributed to the transformation of transmission and also discussed case studies is discussed in this article.


Current Scenario, WHO, Epidemiology, Transmission, Outbreak, New Face

Article Metrics

Article View: 592

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.